Literature DB >> 7429637

Facile penetration of the Staphylococcus aureus capsule by lysostaphin.

B F King, M L Biel, B J Wilkinson.   

Abstract

The ability of macromolecules to cross the capsular layer of encapsulated microorganisms and interact with their cell walls is important in considerations of the mechanisms of resistance to phagocytosis and of antigen masking in such strains. Lysostaphin was employed as a probe of the penetrability of the Staphylococcus aureus capsule. The rates of lysostaphin-induced lysis of encapsulated and unencapsulated S. aureus strains were compared. Encapsulated S. aureus strains M and Smith diffuse were lysed by lysostaphin at the same rate as their respective unencapsulated counterpart strains M variant and Smith compact. Growth of the M strain in a medium designed to enhance capsule production did not delay the onset or decrease the rate of lysis of the strain compared with organisms grown in normal medium. Cations did not selectively decrease the rate of lysis of the encapsulated strain, but inhibited the lysis of both the M and M variant strains. Peptidoglycan, the presumed lysostaphin target, isolated from both M and M variant strains was digested by lysostaphin at very similar rates. In contrast to whole cells, cations stimulated the rate of lysostaphin digestion of peptidoglycan. It is concluded that the fraction of lysostaphin active in cell lysis, believed to be a glycylglycine endopeptidase with a molecular weight of about 25,000, passes freely through the capsular layer to its target in the staphylococcal cell wall.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7429637      PMCID: PMC551214          DOI: 10.1128/iai.29.3.892-896.1980

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  21 in total

1.  Inhibition of phage infection by pneumococcus capsule.

Authors:  H P Bernheimer; J G Tiraby
Journal:  Virology       Date:  1976-08       Impact factor: 3.616

2.  Structural analysis of the surface polysaccharide of Staphylococcus aureus M.

Authors:  D F Liau; J H Hash
Journal:  J Bacteriol       Date:  1977-07       Impact factor: 3.490

Review 3.  Bacterial exopolysaccharides.

Authors:  I W Sutherland
Journal:  Adv Microb Physiol       Date:  1972       Impact factor: 3.517

4.  Immunoglobulins as aspecific opsonins. II. The influence of specific and aspecific immunoglobulins on the in vitro phagocytosis of noncapsulated, capsulated, and decapsulated bacteria by human neutrophils.

Authors:  M W Stinson; C J Van Oss
Journal:  J Reticuloendothel Soc       Date:  1971-05

5.  The effect of antibiotics on synthesis of mucopeptide and teichoic acid by Pediococcus cerevisiae and by a substrain that requires methicillin for growth.

Authors:  B J Wilkinson; P J White
Journal:  J Gen Microbiol       Date:  1973-12

6.  Molecular properties of lysostaphin, a bacteriolytic agent specific for Staphylococcus aureus.

Authors:  H R Trayer; C E Buckley
Journal:  J Biol Chem       Date:  1970-09-25       Impact factor: 5.157

7.  The sensitivity to complement of strains of Escherichia coli related to their K antigens.

Authors:  A A Glynn; C J Howard
Journal:  Immunology       Date:  1970-03       Impact factor: 7.397

8.  Molecular sieving by the Bacillus megaterium cell wall and protoplast.

Authors:  R Scherrer; P Gerhardt
Journal:  J Bacteriol       Date:  1971-09       Impact factor: 3.490

9.  A new type of penicillin resistance of Staphylococcus aureus.

Authors:  L D Sabath; N Wheeler; M Laverdiere; D Blazevic; B J Wilkinson
Journal:  Lancet       Date:  1977-02-26       Impact factor: 79.321

10.  Relation of mucoid growth of Staphylococcus aureus to clumping factor reaction, morphology in serum-soft agar, and virulence.

Authors:  K Yoshida; R D Ekstedt
Journal:  J Bacteriol       Date:  1968-10       Impact factor: 3.490

View more
  7 in total

Review 1.  Bactericidal and bacteriolytic activity of serum against gram-negative bacteria.

Authors:  P W Taylor
Journal:  Microbiol Rev       Date:  1983-03

2.  Staphylococcus aureus mutants with increased lysostaphin resistance.

Authors:  Angelika Gründling; Dominique M Missiakas; Olaf Schneewind
Journal:  J Bacteriol       Date:  2006-09       Impact factor: 3.490

3.  Removal of Paracoccus denitrificans outer membrane material by sodium chloride.

Authors:  M S Hindahl; S Wee; D H Banks; J C Tsang; B J Wilkinson
Journal:  Arch Microbiol       Date:  1981-12       Impact factor: 2.552

4.  Binding of human immunoglobulin G to protein A in encapsulated Staphylococcus aureus.

Authors:  B F King; B J Wilkinson
Journal:  Infect Immun       Date:  1981-09       Impact factor: 3.441

5.  Human fibronectin binding to staphylococcal surface protein and its relative inefficiency in promoting phagocytosis by human polymorphonuclear leukocytes, monocytes, and alveolar macrophages.

Authors:  H A Verbrugh; P K Peterson; D E Smith; B Y Nguyen; J R Hoidal; B J Wilkinson; J Verhoef; L T Furcht
Journal:  Infect Immun       Date:  1981-09       Impact factor: 3.441

Review 6.  Lysostaphin: A Staphylococcal Bacteriolysin with Potential Clinical Applications.

Authors:  Maria do Carmo de Freire Bastos; Bruna Gonçalves Coutinho; Marcus Lívio Varella Coelho
Journal:  Pharmaceuticals (Basel)       Date:  2010-04-19

Review 7.  Nanozybiotics: Nanozyme-Based Antibacterials against Bacterial Resistance.

Authors:  Caiyu Zhou; Qian Wang; Jing Jiang; Lizeng Gao
Journal:  Antibiotics (Basel)       Date:  2022-03-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.